Bilateral renal sinus myelolipomas

Authors

  • Ashley Cox Department of Urology, Dalhousie University, Halifax, NS
  • Saul L. Offman Division of Anatomical Pathology and Department of Pathology, Dalhousie University, Halifax, NS
  • Jennifer L.O. Merrimen Division of Anatomical Pathology and Department of Pathology, Dalhousie University, Halifax, NS
  • Andrea Kew Division of Hematology, Dalhousie University, Halifax, NS
  • Richard W. Norman Department of Urology, Dalhousie University, Halifax, NS

DOI:

https://doi.org/10.5489/cuaj.971

Abstract

Adrenal myelolipomas are benign neoplasms consisting of hematopoietic
cellular elements and adipose tissue. They are uncommon,
found in 0.4% to 1% of the population at autopsy. Extraadrenal
myelolipomas (EM) are extremely rare with fewer than
50 cases reported. We describe the first case of bilateral EM of
the renal sinus. They are difficult to diagnose on imaging alone
when arising in this location and biopsies may not yield a definitive
answer. Management options include both conservative and
surgical approaches depending upon the certainty of the diagnosis,
progression of the patient’s symptoms and evidence of growth.

Downloads

Download data is not yet available.

Author Biographies

Ashley Cox, Department of Urology, Dalhousie University, Halifax, NS

Saul L. Offman, Division of Anatomical Pathology and Department of Pathology, Dalhousie University, Halifax, NS

Jennifer L.O. Merrimen, Division of Anatomical Pathology and Department of Pathology, Dalhousie University, Halifax, NS

Andrea Kew, Division of Hematology, Dalhousie University, Halifax, NS

Richard W. Norman, Department of Urology, Dalhousie University, Halifax, NS

Downloads

How to Cite

Cox, A., Offman, S. L., Merrimen, J. L., Kew, A., & Norman, R. W. (2013). Bilateral renal sinus myelolipomas. Canadian Urological Association Journal, 4(6), E164-E168. https://doi.org/10.5489/cuaj.971

Issue

Vol. 4 No. 6 (2010): CUAJ December

Section

Case Report

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.